Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Project Name | Project Stage | Molecule Type | Host Species | Therapeutic Area | Indications |
| CDH6 mAb - 01 | PCC | Solid Tumor | Ovarian cancer,Renal cell carcinoma |
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| CA6-R52H3 | Rat | Rat Cadherin-6 / KCAD / CDH6 Protein, His Tag (MALS verified) |  |
|
|
| CHEK-ATP127 | Human | HEK293/Human Cadherin-6 Stable Cell Line | |||
| CA6-H82E3 | Human | Biotinylated Human Cadherin-6 / KCAD / CDH6 Protein, His,Avitag™ (MALS verified) |  |
|
|
| CA6-M52H8 | Mouse | Mouse Cadherin-6 / KCAD / CDH6 Protein, His Tag |  |
|
|
| CA6-C52H3 | Cynomolgus / Rhesus macaque | Cynomolgus / Rhesus macaque Cadherin-6 / KCAD / CDH6 Protein, His Tag |  |
|
|
| CA6-H5258 | Human | Human Cadherin-6 / KCAD / CDH6 Protein, Fc Tag (MALS verified) |  |
|
|
| CA6-H5229 | Human | Human Cadherin-6 / KCAD / CDH6 Protein, His Tag |  |
|
|
Expression analysis of human Cadherin-6 on HEK293/Human Cadherin-6 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human Cadherin-6 Stable Cell Line or negative control cell using anti-human Cadherin-6 antibody followed by staining with PE anti-human IgG Fc antibody.
Immobilized Human Anti-Cadherin-6 at 1 μg/mL (100 μL/well) can bind Biotinylated Human Cadherin-6 Protein, His,Avitag (Cat. No. CA6-H82E3) with a linear range of 0.2-16 ng/mL (QC tested).
The purity of Rat Cadherin-6 Protein, His Tag (Cat. No. CA6-R52H3) is more than 90% and the molecular weight of this protein is around 60-90 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Raludotatug deruxtecan | DS-6000a; DS6000a; DS-6000; R-DXd | Phase 3 Clinical | Daiichi Sankyo Co Ltd | Ovarian Neoplasms; Solid tumours; Carcinoma, Renal Cell; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| SIM-0505 | SIM-0505 | Phase 1 Clinical | Hainan Xiansheng Re Ming Pharmaceutical Co Ltd | Solid tumours | Details |
| AMT-707 | AMT-707; CUSP-06 | Phase 1 Clinical | Multitude Therapeutics Inc | Solid tumours; Ovarian Neoplasms; Carcinoma, Renal Cell; Cholangiocarcinoma | Details |
This web search service is supported by Google Inc.
A-Z
